National Dentex Corporation (NASDAQ: NADX), one of the largest
owner/operators of dental laboratories in the United States, today
announced its results for the fourth quarter and year ended
December 31, 2009. For the full year ended December 31, 2009,
National Dentex reported sales of $161,195,000, a 6.1% decline from
reported sales of $171,674,000 for the same period in 2008. Net
income for 2009 increased to $5,877,000, or $1.02 per diluted
share, from a net loss of $877,000, or a $.16 loss per diluted
share, for fiscal 2008. Non-GAAP net income was $6,141,000 for
fiscal 2009, or $1.07 per diluted share, compared to $5,240,000 for
fiscal 2008, or $.93 per diluted share. Non-GAAP net income
excludes non-cash goodwill impairment charges, including the tax
effect. National Dentex recorded non-cash goodwill impairment
charges of $6,950,000 in the fourth quarter of 2008 and $264,000 in
the third quarter of 2009. These charges were taken with respect to
certain laboratories in connection with management’s assessment of
goodwill on its balance sheet and did not affect the Company’s cash
flow. A reconciliation of Non-GAAP net income to net income is
included at the end of this press release.
For the fourth quarter of 2009, National Dentex reported sales
of $38,174,000, which was 7.5% lower than the fourth quarter sales
in 2008 of $41,264,000. Net income for the quarter was $429,000, or
$.07 per diluted share, compared to a net loss of $5,286,000, or a
loss of $.93 per diluted share in 2008. Non-GAAP net income was
$429,000, or $.07 per diluted share, for the fourth quarter of 2009
compared to $831,000, or $.15 per diluted share, for the same
period in 2008. The difference is primarily attributable to a tax
credit related to research activities from tax year 2002, recorded
in the fourth quarter of 2008 as a result of the expiration of the
final statute of limitations for IRS modification. The after tax
effect on net income in the fourth quarter of 2008 for this item
was $468,000, or $.08 per diluted share.
Commenting on today’s announcement, David Brown, Chairman and
CEO, stated: “As a result of a very difficult consumer market, 2009
has been a challenging year for the dental laboratory industry.
While we are beginning to see improving trends, we continue to feel
the effects of the industry-wide slowdown in revenues brought on by
a decline in discretionary consumer spending. In response, we have
made great strides in controlling our production and operating
costs, in particular our labor and related payroll expenses. As a
result, we have improved profitability in 2009. In addition, we
have continued to make advances with newer technologies that we
believe will enhance our competitive advantages in the future.”
Use of Non-GAAP Financial
Measures
This press release contains non-GAAP financial measures,
specifically Non-GAAP net income and Non-GAAP net income per share.
Non-GAAP net income equals net income plus non-cash goodwill
impairment charges, including the tax effect, which comprise of the
goodwill impairment charges described above taken in the fourth
quarter of 2008 and the third quarter of 2009. We believe that the
use of these non-GAAP financial measures in this press release
helps investors gain an understanding of our underlying operating
results without the effect of these non-cash charges, particularly
when comparing to prior periods. These non-GAAP financial measures
are not meant to be considered superior to or a substitute for the
results of operations prepared in accordance with GAAP.
Reconciliations of these non-GAAP financial measures to the most
directly comparable GAAP financial measures are included at the end
of this press release.
About National Dentex
National Dentex Corporation serves an active customer base of
over 24,000 dentists through 44 dental laboratories located in 30
states and one Canadian province. National Dentex's dental
laboratories provide a full range of custom-made dental prosthetic
appliances, including dentures, crowns and fixed bridges, and other
dental specialties.
Safe Harbor Statement
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995
as contained in Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934. You can
identify these statements by the fact that they use words such as
"anticipate," "believe," "estimate," "expect," "intend," "project,"
"plan," "outlook," and other words and terms of similar meaning.
These forward-looking statements are based on our current
expectations, beliefs, assumptions, estimates, forecasts and
projections about the industry and markets in which National Dentex
operates. The forward-looking statements contained in this release
are not guarantees of future performance and involve certain risks,
uncertainties and assumptions that are difficult to predict.
Therefore, actual outcomes and results may differ materially from
what is expressed in such forward-looking statements. Important
factors that may affect future operating results and acquisition
activity include the timing, duration and effects of adverse
changes in overall economic conditions and other developments that
directly or indirectly affect consumer decisions as to whether and
when to have dental procedures performed, including the recent
recession and high unemployment; National Dentex’s ability to
acquire new laboratories on terms and conditions acceptable to it
and its capacity to integrate and successfully operate previously
acquired laboratories; governmental regulation of health care;
trends in the dental industry towards managed care; increases in
labor, benefits and material costs; product development risks;
technological innovations; competition from other dental
laboratories, including increased competition from dental
laboratories located in foreign countries with lower labor and
benefit costs, such as China; National Dentex’s ability to attract,
retain and motivate qualified personnel; changes in the cost or
availability of raw materials, particularly precious metals like
gold and palladium; any impairment in the carrying value of
goodwill or other acquired intangibles; National Dentex’s ability
to access the credit markets on commercially reasonable terms;
compliance with evolving federal securities, accounting, and
marketplace rules and regulations applicable to publicly-traded
companies on the NASDAQ Global Market; and other risks indicated
from time to time in National Dentex’s filings with the Securities
and Exchange Commission, particularly under Item 1A, “Risk Factors”
of National Dentex’s most recently filed Annual Report on Form 10-K
and our other periodic reports filed with the SEC. National Dentex
assumes no obligation to update the information included in this
press release, whether as a result of new information, future
events or otherwise.
National Dentex
Corporation
Earnings Results
(Unaudited)
(In Thousands, except per share
data)
Quarter Ended Twelve Months Ended
December 31,
December 31,
2008
2009
2008
2009
Net Sales $ 41,264 $ 38,174 $ 171,674 $ 161,195 Cost of
Goods Sold
25,202
22,385
102,184
93,120
Gross Profit
16,062
15,789
69,490
68,075
Goodwill Impairment 6,950 - 6,950 264 Operating Expenses
14,594
14,402
58,588
55,755
Operating Income (5,482) 1,387 3,952 12,056 Other Expense
166 125 747 744 Interest Expense - Net
568
240
2,110
1,257
Income Before Tax (6,216) 1,022 1,095 10,055 Income Taxes
(930)
593
1,972
4,178
Net Income
$
(5,286)
$
429 $ (877)
$ 5,877 Weighted Average
Shares Outstanding:
- Basic 5,655 5,761 5,631 5,727 - Diluted 5,655 5,859 5,631 5,761
Net Income per Share: - Basic $ (.93) $ .07 $ (.16) $ 1.03 -
Diluted $ (.93) $ .07 $ (.16) $ 1.02
National Dentex
Corporation
Selected Balance Sheet
Data
(Unaudited)
(In thousands)
December 31,
2008
December 31,
2009
Cash and Equivalents $ 2,110 $ 1,510 Accounts
Receivable – net 19,228 17,862 Current Assets 33,019 31,019
Current Liabilities 23,492 21,724 Working Capital 9,527
9,295 Total Assets 161,515 155,295 Long Term
Obligations 47,531 35,781 Stockholders’ Equity $ 90,492 $ 97,790
National Dentex
Corporation
Reconciliation of Net Income to
Non-GAAP Net Income
(Unaudited)
(In Thousands, except per share
data)
Quarter Ended Twelve Months Ended
December 31,
December 31,
2008
2009
2008
2009
Net income (loss)
$
(5,286)
$ 429 $ (877) $ 5,877 Add back: Goodwill impairment 6,950 -
6,950 264 Tax effect of goodwill Impairment
(833)
-
(833)
-
Non-GAAP net income * 831 429 5,240 6,141 Weighted
Average shares – basic 5,655 5,761 5,631 5,727 Weighted Average
shares - diluted
5,655
5,859
5,631
5,761
Net income (loss) per share – basic
$
(.93)
$ .07 $ (.16) $ 1.03 Net income (loss) per share – diluted
$
(.93)
$ .07 $ (.16) $ 1.02 Non-GAAP net income per share – basic *
$
.15
$ .07 $ .93 $ 1.07 Non-GAAP net income per share –diluted *
$
.15
$ .07 $ .93 $ 1.07
*Non-GAAP net income excludes the goodwill impairment charges
of $6,950,000 taken in the fourth quarter of 2008 and $264,000
taken in the third quarter of 2009, as well as the tax effect
resulting therefrom.
National Dentex (NASDAQ:NADX)
Historical Stock Chart
From Nov 2024 to Dec 2024
National Dentex (NASDAQ:NADX)
Historical Stock Chart
From Dec 2023 to Dec 2024